VoiceLove: An App-Based COMMunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)

ConditionsCritical Illness Intensive Care Medicine

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorVanderbilt University Medical Center

About this trial

VoiceLove is a phone application allowing family and patients to share information in a secure platform. This project will compare the VoiceLove app to usual care to learn about whether VoiceLove improves patient-family communication, family engagement, and ICU delirium.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Adult patient ≥18 years old

Admitted to medical or coronary ICU

Intubated on mechanical ventilation with expected intubation of > 24 hours

Inability to obtain informed consent

Trial design

Design model

Parallel

Treatments tested in this trial

Communication Application
Other intervention
Participants will receive the VoiceLove intervention versus the standard care which does not utilize VoiceLove.

Treatment groups

100 Participants

are divided into 2 treatment groups

Group A: Usual Care recipientsNo intervention 0 interventions

Group B: VoiceLove recipientsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

To assess communication and engagement among patients and family members during hospitalization. The primary feasibility outcome is app engagement among participants randomized to the intervention arm.

Engagement will be characterized using prespecified metrics, including the number of messages played to the patient, duration of app use, and other measures of app utilization during the ICU stay.

Time frame

Up to 14 days

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Vanderbilt University Medical Center

Lead sponsor

Source ClinicalTrials.gov

Apply now